BELGRAVIA CAPITAL INTERNATIONAL INC. announced the execution of a letter of intent with R&D Pharma, to collaborate in the development of Belgravia's distributed and decentralized blockchain medical cannabis provenance and quality attestation database. The provisions of the Letter of Intent with R&D Pharma include: R&D will provide validated input data regarding concentration of Cannabinoids in products, and other active ingredients, and levels of any impurities which will be required to be consistent with established standards; R&D will provide references on the blockchain will be provided to off-chain documents including hash indexes to reports of independent analytical labs for microbiology, heavy metals, pesticides, and metabolites; Belgravia will invite R&D to be a permissioned node on the distributed blockchain; and Revenue sharing models will be negotiated in due course, and as business cases are further evaluated, and a significant number of additional industry players, regulators, and consumer conduits are established through social media marketing and other consumer outreach forums.